| Potassium as a link between insulin and the renin-angiotensin-aldosterone system. | |
| | |
MedLine Citation:
|
PMID: 1619503 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
PURPOSE: To focus on the interactions between insulin secretion, glucose tolerance and insulin sensitivity on the one hand and the renin-angiotensin-aldosterone system on the other. EFFECTS ON INSULIN: Insulin is a potent stimulus for hypokalaemia, sparing body potassium from urinary excretion by transporting it into cells. Potassium also appears to play a key role in the antinatriuretic effect of insulin. Insulin-induced hypokalaemia increases plasma renin and angiotensin II levels while decreasing the serum aldosterone concentration. In turn, the renin-angiotensin-aldosterone system affects glucose tolerance by modulating plasma potassium levels, which act as a stimulus for glucose-induced insulin release. EFFECTS OF ANGIOTENSIN CONVERTING ENZYME (ACE) INHIBITION: Interference with the renin-angiotensin-aldosterone system by ACE inhibition blunts the hypokalaemic response to insulin, thereby improving glucose-induced insulin release and oral glucose tolerance. ACE inhibition, however, does not cause major changes in insulin sensitivity. POTASSIUM AND BLOOD PRESSURE: Plasma potassium levels are inversely related to blood pressure, both in population surveys and in intervention studies. In addition, in patients with essential hypertension, the level of plasma potassium appears to predict the blood pressure response to ACE inhibition. SUMMARY: Potassium metabolism is an important link between carbohydrate metabolism and the renin-angiotensin-aldosterone system by way of a double-feedback mechanism. Through the potential effects on blood pressure control, plasma levels of potassium represent a link between insulin and blood pressure in humans. |
| | |
Authors:
|
E Ferrannini; A Q Galvan; D Santoro; A Natali |
Related Documents
:
|
3773323 - A kindred of familial combined hyperlipidemia (fchl) with proband showing type v hyperl... 19506563 - The accelerator hypothesis: a review of the evidence for insulin resistance as the basi... 16103693 - Retinopathy in newly diagnosed type 2 diabetes mellitus. |
Publication Detail:
|
Type: Journal Article; Review |
Journal Detail:
|
Title: Journal of hypertension. Supplement : official journal of the International Society of Hypertension Volume: 10 ISSN: 0952-1178 ISO Abbreviation: J Hypertens Suppl Publication Date: 1992 Apr |
Date Detail:
|
Created Date: 1992-07-31 Completed Date: 1992-07-31 Revised Date: 2005-11-16 |
Medline Journal Info:
|
Nlm Unique ID: 8501422 Medline TA: J Hypertens Suppl Country: ENGLAND |
Other Details:
|
Languages: eng Pagination: S5-10 Citation Subset: IM |
Affiliation:
|
CNR Institute of Clinical Physiology, University of Pisa, Italy. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Angiotensin-Converting Enzyme Inhibitors
/
therapeutic use* Blood Glucose / metabolism Blood Pressure / drug effects Diabetic Angiopathies / drug therapy*, physiopathology Feedback / physiology Humans Hypertension / drug therapy*, physiopathology Insulin / physiology*, secretion Potassium / physiology* Renin-Angiotensin System / physiology* |
| Chemical | |
Reg. No./Substance:
|
0/Angiotensin-Converting Enzyme Inhibitors; 0/Blood Glucose; 11061-68-0/Insulin; 7440-09-7/Potassium |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Micro-albuminuria and the organ-damage concept in antihypertensive therapy for patients with insulin...
Next Document: [Comparison of CT and MRI in diagnosis of parapharyngeal tumors].